Diadenosine Polyphosphates’ Action on Calcium and Vessel Contraction

The effects of the endogenous, platelet-derived vasoactive compounds, diadenosine tetraphosphate (AP4A), diadenosine pentaphosphate (AP5A), and diadenosine hexaphosphate (AP6A) on the vasoconstriction of isolated rat renal resistance vessels and rat aortic strips were measured using a vessel myograph. In addition, the effects of AP4A, AP5A, and AP6A on the cytosolic free calcium concentration ([Ca2+]i) were evaluated in cultured rat vascular smooth muscle cells (VSMC) using the fluorescent dye technique. Diadenosine polyphosphates dose-dependently increased the force of renal resistance vessels and isolated aortic strips. The administration of 10 μmol/L AP4A, AP5A, or AP6A significantly increased the force of isolated renal resistance vessels by 3.48 ± 0.43 mN (n = 8), 2.14 ± 0.40 mN (n = 12), or 2.70 ± 0.31 mN (n = 11, each P< .01 compared with resting tension), respectively. The administration of 10 μmol/L AP4A, AP5A, or AP6A significantly increased the force of isolated aortic strips by 2.45 ± 0.97 mNewton (n = 10), 2.70 ± 0.30 mN (n = 6), or 1.48 ± 0.20 mN (each P< .01 compared with resting tension), respectively. The administration of 10 μmol/L AP4A, AP5A, or AP6A significantly increased [Ca2+]i in VSMC to a peak concentration of 314 ± 60 nmol/L (n = 6), 247 ± 25 nmol/L (n = 15), or 332 ± 100 nmol/L (n = 5), respectively (each P< .01 compared with resting value). Both the diadenosine polyphosphate-induced vasoconstriction and [Ca2+]i increase was significantly reduced in the absence of extracellular calcium or after administration of a specific inhibitor of P2 purinoceptors. It is concluded that diadenosine polyphosphates increase [Ca2+]i and hence cause vessel constriction.